A Selection of Recent Stem Cell News

Stem cell research forges ahead these days on too many fronts to keep up with more than the high points. It's still enormously, unnecessarily expensive and time consuming to bring perfectly serviceable cell therapies into clinical practice in the US, so the medical tourism market continues to grow. The bulk of practical experience in the use of early stage stem cell therapies is at this point distributed to less regulated parts of the world, I believe. Work in the laboratory continues to advance in leaps and bounds, meanwhile, ever further ahead of what government regulators are willing to let pass their increasingly ridiculous testing processes. Researchers are moving closer to using stem cells to build useful amounts of tissue, and in programming stem cells to behave as we'd like them to behave: more active involvement in tissue regeneration, for example. There is a still a great deal yet to learn about how stem cells are programmed, however. Here is a selection of recent news, a cross section of the average state of progress in stem cell research and the business of moving discoveries into clinical practice. Stem Cells Market Will Reach USD 119.51 Billion in 2018 The market growth is majorly attributed to therapeutic research activities led by government support worldwide owing to the growing number of patients with chronic diseases across the globe. In addition, rising awareness of regenerative treatment options and growing importance of stem cell banking services are ...
Source: Fight Aging! - Category: Health Medicine and Bioethics Commentators Authors: Tags: Daily News Source Type: blogs